Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom
2014 · Clinical Drug Investigation · 26 citations
https://doi.org/10.1007/s40261-014-0240-z
K
K. Thokagevistk
Roche (France)(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
96
Citations
6
h-index
3
i10-index
K. Thokagevistk is an academic researcher from Roche (France). The author has contributed to research in topics: Pharmaceutical Economics and Policy & Health Systems, Economic Evaluations, Quality of Life & Lung Cancer Treatments and Mutations. The author has an h-index of 6, co-authored 27 publications.
Papers by this author
worksAddressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer
2025 · BMC Medical Research Methodology · 1 citations
https://doi.org/10.1186/s12874-025-02500-w
HSD105 Subcutaneous vs. Intravenous Administration in Oncology: A Literature Review of Impacts on Patients, Providers, and Hospitals
2025 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2025.09.1766
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat